Showing results (61-70 of 172) with videos related to
Sort By:
Pageof 18
Plos One|June 4, 2010
Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcomaMichiro Susa, Arun K Iyer, Keinosuke Ryu, et al.Oncotarget|April 19, 2017
Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cellsYunfei Liao, Lulu Chen, Yong Feng, et al.European Journal of Cancer (Oxford, England : 1990)|January 7, 2014
Comparison of performance of various tumour response criteria in assessment of regorafenib activity in advanced gastrointestinal stromal tumours after failure of imatinib and sunitinibAtul B Shinagare, Jyothi P Jagannathan, Vikram Kurra, et al.Genes, Chromosomes & Cancer|November 19, 2025
"Benign" Metastasizing Fibrous Histiocytoma Harboring PRKCD Gene Fusions With Malignant Clinical CourseCharlotte I Wang, Anne B Giersch, Santiago Lozano Calderon, et al.Molecular Oncology|February 2, 2017
miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivoZhenfeng Duan, Yan Gao, Jacson Shen, et al.Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 31, 2009
Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expressionZhenfeng Duan, Edwin Choy, G Petur Nielsen, et al.International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
Secondary Acute Leukemia in Sarcoma Patients: A Population-Based StudyNina N Sanford, Allison M Martin, Andrew M Brunner, et al.Plos One|October 3, 2013
Tissue microarray immunohistochemical detection of brachyury is not a prognostic indicator in chordomaLinlin Zhang, Shang Guo, Joseph H Schwab, et al.Gynecologic Oncology|February 14, 2015
NSC23925 prevents the emergence of multidrug resistance in ovarian cancer in vitro and in vivoXiaoqian Yang, Yong Feng, Yan Gao, et al.The American Journal of Surgical Pathology|August 23, 2020
Chondroblastoma Expresses RANKL by RNA In Situ Hybridization and May Respond to Denosumab TherapyDavid I Suster, Pawel Kurzawa, Azfar Neyaz, et al.Pageof 18